4.40
前日終値:
$4.32
開ける:
$4.36
24時間の取引高:
152.05K
Relative Volume:
0.86
時価総額:
$81.56M
収益:
$117.59M
当期純損益:
$-74.85M
株価収益率:
-1.0539
EPS:
-4.175
ネットキャッシュフロー:
$-34.25M
1週間 パフォーマンス:
+13.99%
1か月 パフォーマンス:
-2.65%
6か月 パフォーマンス:
-0.90%
1年 パフォーマンス:
-75.49%
Outset Medical Inc Stock (OM) Company Profile
Compare OM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OM
Outset Medical Inc
|
4.40 | 80.08M | 117.59M | -74.85M | -34.25M | -4.175 |
|
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | 開始されました | BTIG Research | Buy |
| 2024-04-05 | アップグレード | CL King | Neutral → Buy |
| 2024-01-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-17 | 開始されました | CL King | Neutral |
| 2022-11-11 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-07-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | 開始されました | Cowen | Outperform |
| 2021-04-19 | 開始されました | Wells Fargo | Overweight |
| 2020-12-16 | 開始されました | Oppenheimer | Perform |
| 2020-10-12 | 開始されました | Barclays | Overweight |
| 2020-10-12 | 開始されました | BofA Securities | Buy |
| 2020-10-12 | 開始されました | Goldman | Buy |
| 2020-10-12 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-12 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-10-12 | 開始されました | Stifel | Buy |
すべてを表示
Outset Medical Inc (OM) 最新ニュース
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa
Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria
Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan
BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan
Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan
Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN
OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan
OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan
OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan
Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan
Woodline Partners holds 292,437 OM shares (1.6%) (OM) - Stock Titan
BTIG Maintains Outset Medical (OM) Buy Recommendation - MSN
Outset Medical (OM) Q1 2026 Earnings Transcript - AOL.com
Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey
BML Investment Partners files 13G/A reporting 11.8% stake in Outset Medical (OM) - Stock Titan
Outset Medical (OM) 10% holder entities exercise derivatives to acquire over 294K shares - Stock Titan
Outset Medical to Present at RBC Global Healthcare Conference - The Manila Times
Dialysis tech firm Outset Medical to speak at RBC health conference - Stock Titan
Outset Medical net revenue drops 6% to USD 27.9M in Q1 2026 - Medical Buyer
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical (OM) Q4 2025 Earnings Transcript - The Globe and Mail
Outset Medical (OM) Receives a Hold from RBC Capital - The Globe and Mail
Outset Medical Bets on Margin Gains and Next-Gen Tableau - TipRanks
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Outset Medical, Inc. Q1 2026 SEC 10-Q Report – Financial Statements, Management Discussion, and Key Risks - Minichart
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Q1 2026 Outset Medical Inc Earnings Call Transcript - GuruFocus
Outset Medical Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus - Investing.com
Earnings call transcript: Outset Medical’s Q1 2026 results show optimism with strategic focus By Investing.com - Investing.com South Africa
Outset Medical : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Outset Medical Inc. (OM) Misses Q1 EPS by 83c - StreetInsider
Outset Medical, Inc. 1Q 2026: Revenue $27.86M, EPS $(1.03) — 10-Q Summary - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
[10-Q] Outset Medical, Inc. Quarterly Earnings Report - Stock Titan
Outset Medical Inc (OM) 財務データ
収益
当期純利益
現金流量
EPS
Outset Medical Inc (OM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nash Marc | EVP Operations R&D & Service |
May 15 '26 |
Sale |
3.70 |
1,582 |
5,853 |
38,393 |
| Brottem John L. | General Counsel |
May 15 '26 |
Sale |
3.70 |
2,638 |
9,761 |
30,277 |
大文字化:
|
ボリューム (24 時間):